Introduction
Midkine is a heparin-binding growth factor with rich basic amino acids and cysteine. 1, 2 Midkine has various biological activities, that is, neurite extension, 3, 4 survival of embryonal nerve cells, [5] [6] [7] protection against constant light-induced retinal degeneration, 8 and enhancement of fibrinolytic activity of endothelial cells. 9 The expression of midkine is intensely induced in the surrounding ischemic zone but not in the necrotic lesion in the early stage of cerebral infarction, 10 where apoptotic DNA fragmentation occurs. 11 In addition, midkine inhibits apoptosis in cultured neurons 12 and in hippocampal neurons after transient ischemia. 13 These findings support that midkine may have neuroprotective actions on the cerebral ischemia.
Gene therapy may be an attractive treatment of cerebrovascular disease. 14, 15 Previous experimental studies have demonstrated the efficacy of gene transfer for brain ischemia. [16] [17] [18] Although recent studies have demonstrated that gene transfer of neurotrophic factors such as glial cell line-derived neurotrophic factor and hepatocyte growth factor inhibits ischemic cerebral damages, 19, 20 most of these gene were delivered before induction of ischemia, and the efficacy of postischemic gene therapy is still not clear. Therefore, we examined whether postischemic gene transfer of midkine had protective effects against cerebral ischemia using the rat middle cerebral artery occlusion model.
Results

Overexpression of midkine in cerebrospinal fluid (CSF)
We used a replication-deficient recombinant adenovirus with the cytomegalovirus immediate early promoter, carrying bacterial b-galactosidase (Adbgal) as control gene, or mouse midkine (AdMK). To determine the secreted midkine in CSF after transgene expression, Western blot analysis was performed with CSF 1 day after administration of AdMK vector into the lateral ventricle. With positive controls, the amount of the midkine in CSF from the rat treated with AdMK (n ¼ 3) was estimated as more than 1 ng per 15 ml, that is, more than 100 ng/ml ( Figure  1) . Adbgal (n ¼ 3) injection and control (n ¼ 3) treatment did not show detectable midkine in CSF. Moreover, pretreatment of heparin markedly augmented the amount of the secreted midkine in AdMK (n ¼ 2) group.
Quantitative analysis of infarct volume
To determine the effect of postischemic gene transfer of midkine, we compared the infarct volume after gene transfer between Adbgal and AdMK. The physiological variables before and after ischemia in Adbgal (n ¼ 7) and AdMK (n ¼ 7) groups are shown in Table 1 . There were no significant differences in the physiological variables between the two groups. In addition, distal middle cerebral artery (MCA) occlusion did not affect these values in each group. Cerebral blood flow (CBF) at the occluded side began to decrease within 10 min after vessel occlusion, and changes in CBF were not different between the two groups ( Figure 2 ).
Gene transfer of midkine attenuated cerebral ischemic damages, mainly at inner parts of parietal cortex, as compared with that of b-galactosidase (Figure 3a, b) . The infarct area was reduced in all sections in AdMK group compared with Adbgal group, and the reduction was significant in the second and third portion of the brain slices (Po0.05 and o0.01, respectively, Figure 3c ). Infarct volume was significantly smaller in AdMK group (51727 mm 3 , n ¼ 7) than that in Adbgal group (86727 mm 3 , n ¼ 7, Po0.05), and the reduction of infarct volume by the gene transfer of midkine was 41% ( Figure  3d ).
Histological study
To determine the antiapoptotic action of midkine, we used terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end-labeling (TUNEL) staining and immunostaining for cleaved caspase-3. In Adbgal group, a large number of the TUNEL-positive cells at the periischemic area of cerebral cortex were observed 2 days after gene transfer (Figure 4a, b) . In contrast, overexpression of midkine reduced the TUNEL-positive cells. The number of TUNEL-positive cells at the caudoputamen level in AdMK group was 1107169 cells/mm 2 (n ¼ 7), which was significantly fewer than that in Adbgal group (5067269 cells/mm 2 , n ¼ 7; Po0.01). As TUNEL-positive cells contain necrotic cells, we also used the immunostaining for cleaved caspase-3, which was a specific product in the apoptotic cells (Figure 4c, d ). The number of cleaved caspase-3-positive cells at the same area with TUNEL staining in AdMK group was 36727 cells/mm 2 (n ¼ 7), which was also significantly fewer than that in Adbgal group (80748 cells/mm 2 , n ¼ 7, Po0.05).
Discussion
In this study, we examined the effect of gene transfer of a neurotrophic factor, midkine, on ischemic brain damages using the thrombotic distal MCA occlusion model in rats. The major new finding of the present study was that overexpression of midkine by postischemic gene transfer markedly reduced cerebral infarct volume.
Basic fibroblast growth factor is known to increase in neurons and astrocytes of the cerebral cortex transiently at the early stage (within 14 days) of permanent brain ischemia, 21 and expression of brain-derived neurotrophic factor also increases transiently in the periischemic cerebral cortex a few hours after brain ischemia. 22 The expression of midkine is also seen in the surrounding ischemic zone in the early stage of cerebral infarction. 10 Previous studies demonstrated that application of several factors such as neurotrophic factors, antiapoptotic materials and antiinflammatory cytokines, reduced Gene transfer of midkine to ischemic brain J Takada et al neuronal damages following ischemia and cerebral infarct volume. [23] [24] [25] [26] Moreover, neuroprotective effects using gene transfer approaches were also demonstrated in some pretreatment studies. 16, 27, 28 However, the studies that showed effective reductions in infarct size by postischemic gene transfer are limited. 19 Therefore, the present study would provide useful information for the clinical application of the gene therapy for brain infarction.
In a previous study, 29 expression of LacZ gene, a reporter gene, in the ischemic brain was seen by 4-6 h after injection of herpes simplex virus vector using X-gal staining. In another report, 30 transgene expression of LacZ was detected in rat pancreatic acinar cells 6 h after administration of adenoviral vector. We also detected the transgene expression in the ischemic brain 3 h after injection of adenovirus vector encoding LacZ by X-Gal staining (unpublished data). As the reduction of infarct volume was achieved by the gene transfer 90 min after induction of ischemia, we assumed that midkine produced into the lateral ventricles by gene transfer started to work in the ischemic brain within 4-5 h after brain ischemia. Previous studies showed that midkine worked at the concentration of 10-100 ng/ml. 9, 12, 31, 32 In the present study, the concentration of midkine secreted into CSF 1 day after gene transfer was estimated as more than 100 ng/ml, suggesting that the amount of secreted midkine was high enough for the neuroprotective effect at the early phase.
Our results in TUNEL staining and immunostaining for cleaved caspase-3 suggested that one of the mechanisms of midkine for attenuation of ischemic damages was its antiapoptotic action. In a study with cultured neurons, midkine inhibited caspase-dependent apoptosis 
Po0.05 by unpaired t-test.
Gene transfer of midkine to ischemic brain J Takada et al by suppressing the activation of caspase-3 via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. 12 Another study on the cell survival by midkine 33 demonstrated that midkine bound to an LDL receptor-related protein, a transmembrane protein, followed by binding to nucleolin, a nucleocytoplasmic shuttle protein, after internalization, suggesting that nuclear translocation of the midkine complex would be one of the key mechanism for cytoprotective action of midkine. These mechanisms may lead to the attenuation of ischemic damages. Moreover, midkine is reported to increase expression of urokinase-type plasminogen activator and decrease plasminogen activator inhibitor-1 expression in endo- Gene transfer of midkine to ischemic brain J Takada et al thelial cells. 9 Enhanced fibrinolytic activity induced by midkine may also contribute to the reduction of infarct volume. However, further studies are required to elucidate the precise mechanisms.
In conclusion, we demonstrated that postischemic gene transfer of midkine, a neurotrophic factor, produced an enough amount of midkine in the CSF and reduced cerebral infarct volume. The attenuation of ischemic damages by midkine was partly attributable to antiapoptotic actions.
Materials and methods
Adenovirus preparation
We constructed AdMK with the use of a cDNA for mouse midkine as described previously. 34, 35 The identity of the vector was confirmed by DNA sequencing, and secreted midkine into the culture medium were verified by Western blotting. Viral titers were determined by a plaque assay using human embryonic kidney 293 cells. After purification, the virus was suspended in phosphate-buffered saline (PBS) with 3% sucrose, and was kept at -801C until used for the experiment.
Animals and surgical procedure
All animal procedures were approved by the Animal Care and Use Review Committee at Kyushu University (12-053-0). Male spontaneously hypertensive rats (SHRs; age: 7-8 months; weight: 352-450 g) were used for the present study. Surgical procedures used in this study were performed as previously described. 36 Rats were anesthetized with halothane (3% for induction, and 1.5% during the surgical preparation with a face mask, 0.75% after intubation and 0.5% for maintenance). The right femoral artery and vein were cannulated for monitoring mean arterial blood pressure or sampling blood, and for the injection of agents, respectively. The rats were endotracheally intubated, and mechanically ventilated after intravenous injection of pancuronium bromide (an initial dose of 0.3 mg followed by 0.1 mg every 30 min). Rectal and head temperature was maintained at 37 and 361C, respectively, by means of a heating pad and a warming lamp. Rats were mounted on a stereotaxic head holder, and burr holes were drilled above the right parietal and temporal cortices. CBF was measured by laser Doppler flowmetry (ALF21, ADVANCE Co., Ltd, Tokyo, Japan) at 4.0 mm lateral and 1.5 mm posterior to the bregma on the ischemic side.
Brain ischemia and injection of adenoviral vector
Brain ischemia was produced by photochemical occlusion of the distal MCA, as described previously. 37 A krypton laser (wavelength ¼ 568 nm; Innova 301, Coherent Inc., Palo Alto, CA, USA) was used to irradiate the distal MCA at a power of 20 mW. The photosensitizing dye rose bengal (15 mg/ml in 0.9% saline; Wako Pure Chemical, Osaka, Japan) was administered intravenously to a body dose of 20 mg/kg over 90 s simultaneously with 4 min of laser irradiation. At 90 min after the distal MCA occlusion, 30 ml of viral suspension (3 Â 10 10 plaque forming units/ml) was injected into the lateral ventricle on the ischemic side. The burr holes were then covered with bone wax, and the scalp was sutured. The rats were carefully weaned from the respirator, then were returned to their home cages and housed for 2 days.
Measurement of infarct volume
Rats were anesthetized with pentobarbital (50 mg/kg intraperitoneally) and decapitated 2 days after induction of ischemia. The brains were quickly removed and cooled in ice-cold saline for 10 min. After cutting into 2-mm thick coronal sections in a cutting block, the brain slices were then immersed in 2% 2,3,5-triphenyltetrazolium chloride (TTC, Wako Pure Chemical, Osaka, Japan) at 371C for 30 min in the dark. After the rinse with saline, the sections were incubated with 4% formaldehyde (Wako Pure Chemical, Osaka, Japan) for a day. Then the posterior surface of each section was photographed, and the infarct area in the right cerebral cortex, which was indicated by the lack of staining, was determined using NIH Image software (version 1.6.2). Infarct volume was calculated as sum of the infarct area multiplied by thickness of the slice.
Immunohistochemical assay of periischemic cortical region
The brain section at the caudoputamen level was fixed by 4% formaldehyde, embedded in paraffin, and cut into 5-mm thickness of slices. To detect cleavage of genomic DNA, the slice was stained with TUNEL using a kit (In Situ Cell Death Detection Kit POD, Roche, Mannheim, Germany). The slice was counterstained with hematoxylin. Another slice at the same level with TUNEL staining was used for immunostaining for cleaved caspase-3. The immunostaining was performed by avidin-biotin-peroxidase method using a kit (Histofine SAB-PO(R) Kit, Nichirei, Tokyo, Japan). In brief, after deparaffinization, the slices were incubated in PBS containing 0.0002% proteinase K for antigen unmasking. In order to block endogenous peroxidase, the slices were incubated for 30 min with methanol containing 0.3% hydrogen peroxide, followed by blocking with PBS containing 5% bovine serum in skim milk for 30 min at room temperature. The slices were then incubated with the rabbit monoclonal antibody against cleaved caspase-3 (Cell Signaling Technology, Inc., Beverly, MA, USA) diluted in PBS containing 5% bovine serum overnight at 41C. The sections were then washed with PBS containing 0.1% p-(1,1,3,3-tetramethylbutyl)phenol ethoxylate (Triton X-100, Polysciences Inc., Warrington, PA, USA), and incubated for 30 min with the biotinylated anti-rabbit polyclonal antibody, followed by incubation with avidinbiotin-horseradish peroxidase complex. Staining was developed with 3,3 0 -diaminobenzidine tetrahydrochloride (Histofine DAB Substrate Kit, Nichirei, Tokyo, Japan), and lightly counterstained with hematoxylin.
The number of positively stained cells was counted at 3 areas of 0.15 mm 2 each in the periischemic parietal cortical region (3 mm lateral to the midline at caudoputamen level, Figure 4e ) by light microscopy. The total number of positive cells in three areas was expressed as cells/mm 2 .
Detection of midkine in CSF
Other sets of SHRs were injected with either AdMK, Adbgal, or none into the lateral ventricle under pentobarbital anesthesia (50 mg/kg i.p.), and 24 h later, CSF Gene transfer of midkine to ischemic brain J Takada et al was collected from the cisterna magna of rat under pentobarbital anesthesia. A part of the transfected rats (AdMK or Adbgal) were injected with heparin (20 U/kg) into the lateral ventricle 30 min before CSF was collected. CSF was centrifuged at 3000 r.p.m for 5 min at 41C to remove cell components and the supernatant was used for Western blotting to verify the secretion of midkine from the transfected tissue. As the sequence of mouse midkine was highly homologous to that of human, 38 our rabbit antibody to human midkine was crossreactive to mouse midkine, 39 and we used purified human midkine (a generous gift from Dr Ikematsu, Meiji Cell Technology Center, Meiji Milk Products Co., Ltd, Japan) as positive control. The supernatant (15 ml) was electrophoresed on a 12.5%-SDS polyacrylamide gel, and transblotted onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA), which was blocked with BlockAce (Dainippon Pharmaceutical, Osaka, Japan) at 41C overnight. The membrane was probed with the rabbit anti-mouse midkine antibody (dilution, 1:200) in Trisbuffered saline (TBS) containing 10% BlockAce for 45 min at 371C. After washing three times with TBS containing 0.05% Tween-20 (TBST) and once with TBS, the membrane was incubated with an alkaline phosphatase-conjugated goat anti-rabbit IgG (1:4000, Promega, Madison, WI, USA) in TBS containing 10% BlockAce for 30 min at 371C. Protein bands were then visualized by revealing the alkaline phosphatase activity according to the manufacturer's directions.
Statistical analysis
Data were presented as mean7s.d. Differences in the data were analyzed by unpaired t-test, repeated measures ANOVA, and nonparametric Mann-Whitney U-test appropriately. P-values less than 0.05 were considered to be statistically significant.
